ZYUS Life Sciences Corporation Announces Closing of First Tranche of Unit Offering and Issuance of Warrants Pursuant to Previously Announced Loan Agreements and Promissory Note Amendment
Light AI reports Financial Results for Three and Nine Months ended September 30, 2025
Pharmacorp Rx increases bought deal offering to $20M
Mindbio completes phase 2B dosing of depression trial
Ventripoint arranges $542,591 debt settlement
MedX Announces Final Closing of Non-Brokered Private Placement
VitalHub Reports Third Quarter 2025 Results
Nova Leap Health Corp. Posts Best Financial Performance in Company History with Record Q3 2025 Results
Cipher Pharmaceuticals Reports Third Quarter 2025 Results
Cybin to host fiscal Q2 results call Nov. 13
Algernon arranges $500,000 private placement
Medicenna joins Fondazione Melanoma for MDNA11 trial
Bright Minds launches Prader-Willi program
PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering
MindBio Therapeutics Completes Dosing in Landmark Take-Home Phase 2B Microdosing Depression Trial